← The Wire
UPBNasdaq
Upstream Bio, Inc.
Pharmaceutical Preparations · DE · CIK 2022626
Developing treatments for inflammatory diseases, focusing on severe respiratory disorders by targeting the TSLP receptor
$332M
Market cap
$6.93
Last close
+2.7%
1D
+10.0%
5D
663K
Volume
Price · last 39 sessions-25.6%
May 4L $5.92 · H $9.36Jun 29
33
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 10, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 2026DEFA14ADEFA14AApr 16, 2026DEF 14ADEF 14AApr 16, 20268-KMaterial AgreementMar 26, 2026424B5424B5Mar 26, 202610-K10-KMar 26, 20268-KResults of OperationsMar 26, 20268-KResults of Operations · Reg FD DisclosureFeb 11, 20268-KReg FD Disclosure · Company UpdateFeb 11, 202610-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KReg FD Disclosure · Company UpdateSep 2, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteJun 12, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 17, 2025DEF 14ADEF 14AApr 17, 202510-K10-KMar 12, 20258-KResults of OperationsMar 12, 2025SC 13GSC 13GNov 7, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13DSC 13DOct 22, 2024SC 13GSC 13GOct 18, 2024SC 13DSCHEDULE 13DOct 17, 20248-KBylaw AmendmentOct 15, 2024424B4424B4Oct 11, 2024S-1/AS-1/AOct 7, 2024S-1S-1Sep 18, 2024
Insider Activity
In the 90 days to Mar 16, 2026: 5 sold $47K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Sutherland Everett RandChief Executive Officer | Sell | 2,093 | $9.29 | $19K |
| Mar 16, 2026 | Deykin AaronChief Medical Officer | Sell | 894 | $9.29 | $8K |
| Mar 16, 2026 | Gray MichaelCFO and COO | Sell | 852 | $9.29 | $8K |
| Mar 16, 2026 | Houghton AdamChief Business Officer | Sell | 699 | $9.29 | $6K |
| Mar 16, 2026 | Ambrose AllisonGeneral Counsel | Sell | 475 | $9.29 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance